vs
Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and Core Scientific, Inc. (CORZ). Click either name above to swap in a different company.
BillionToOne, Inc. is the larger business by last-quarter revenue ($83.5M vs $79.8M, roughly 1.0× Core Scientific, Inc.). Core Scientific, Inc. runs the higher net margin — 268.5% vs 6.8%, a 261.6% gap on every dollar of revenue. On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs -16.0%). BillionToOne, Inc. produced more free cash flow last quarter ($6.5M vs $-450.8M).
BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.
Core Scientific is a leading digital asset and high-performance computing infrastructure provider. It operates large energy-efficient data centers across North America, offering cryptocurrency mining services, colocation hosting for blockchain and AI clients, and custom high-performance computing solutions for enterprise tech segments.
BLLN vs CORZ — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $83.5M | $79.8M |
| Net Profit | $5.7M | $214.2M |
| Gross Margin | 69.9% | 26.0% |
| Operating Margin | 11.5% | -149.5% |
| Net Margin | 6.8% | 268.5% |
| Revenue YoY | 117.4% | -16.0% |
| Net Profit YoY | 138.3% | 180.6% |
| EPS (diluted) | $0.10 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $79.8M | ||
| Q3 25 | $83.5M | $81.1M | ||
| Q2 25 | — | $78.6M | ||
| Q1 25 | — | $79.5M | ||
| Q4 24 | — | $94.9M | ||
| Q3 24 | $38.4M | $95.4M | ||
| Q2 24 | — | $141.1M | ||
| Q1 24 | — | $179.3M |
| Q4 25 | — | $214.2M | ||
| Q3 25 | $5.7M | $-144.0M | ||
| Q2 25 | — | $-936.8M | ||
| Q1 25 | — | $576.3M | ||
| Q4 24 | — | $-265.5M | ||
| Q3 24 | $-14.9M | $-455.3M | ||
| Q2 24 | — | $-902.2M | ||
| Q1 24 | — | $210.7M |
| Q4 25 | — | 26.0% | ||
| Q3 25 | 69.9% | 4.8% | ||
| Q2 25 | — | 6.4% | ||
| Q1 25 | — | 10.3% | ||
| Q4 24 | — | 5.0% | ||
| Q3 24 | 52.6% | -0.2% | ||
| Q2 24 | — | 27.5% | ||
| Q1 24 | — | 43.3% |
| Q4 25 | — | -149.5% | ||
| Q3 25 | 11.5% | -67.6% | ||
| Q2 25 | — | -33.4% | ||
| Q1 25 | — | -59.1% | ||
| Q4 24 | — | -41.9% | ||
| Q3 24 | -32.9% | -43.2% | ||
| Q2 24 | — | -64.3% | ||
| Q1 24 | — | 30.8% |
| Q4 25 | — | 268.5% | ||
| Q3 25 | 6.8% | -177.6% | ||
| Q2 25 | — | -1191.4% | ||
| Q1 25 | — | 724.6% | ||
| Q4 24 | — | -279.7% | ||
| Q3 24 | -38.8% | -477.4% | ||
| Q2 24 | — | -639.4% | ||
| Q1 24 | — | 117.5% |
| Q4 25 | — | $-1.63 | ||
| Q3 25 | $0.10 | $-0.45 | ||
| Q2 25 | — | $-0.04 | ||
| Q1 25 | — | $1.24 | ||
| Q4 24 | — | $0.51 | ||
| Q3 24 | $-1.47 | $-1.17 | ||
| Q2 24 | — | $-5.05 | ||
| Q1 24 | — | $0.78 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $195.2M | $311.4M |
| Total DebtLower is stronger | $55.0M | — |
| Stockholders' EquityBook value | $-239.5M | $-962.7M |
| Total Assets | $327.5M | $2.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $311.4M | ||
| Q3 25 | $195.2M | $453.4M | ||
| Q2 25 | — | $581.3M | ||
| Q1 25 | — | $697.9M | ||
| Q4 24 | — | $836.2M | ||
| Q3 24 | — | $253.0M | ||
| Q2 24 | — | $96.1M | ||
| Q1 24 | — | $98.1M |
| Q4 25 | — | — | ||
| Q3 25 | $55.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $-962.7M | ||
| Q3 25 | $-239.5M | $-1.3B | ||
| Q2 25 | — | $-1.2B | ||
| Q1 25 | — | $-308.8M | ||
| Q4 24 | — | $-943.0M | ||
| Q3 24 | $-242.9M | $-826.7M | ||
| Q2 24 | — | $-1.2B | ||
| Q1 24 | — | $-318.5M |
| Q4 25 | — | $2.3B | ||
| Q3 25 | $327.5M | $2.2B | ||
| Q2 25 | — | $1.9B | ||
| Q1 25 | — | $1.5B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | $824.6M | ||
| Q2 24 | — | $664.2M | ||
| Q1 24 | — | $814.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $13.8M | $278.3M |
| Free Cash FlowOCF − Capex | $6.5M | $-450.8M |
| FCF MarginFCF / Revenue | 7.7% | -565.1% |
| Capex IntensityCapex / Revenue | 8.8% | 914.0% |
| Cash ConversionOCF / Net Profit | 2.42× | 1.30× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-779.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $278.3M | ||
| Q3 25 | $13.8M | $131.8M | ||
| Q2 25 | — | $34.0M | ||
| Q1 25 | — | $-45.0M | ||
| Q4 24 | — | $42.9M | ||
| Q3 24 | — | $5.7M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $22.2M |
| Q4 25 | — | $-450.8M | ||
| Q3 25 | $6.5M | $-112.7M | ||
| Q2 25 | — | $-87.3M | ||
| Q1 25 | — | $-129.0M | ||
| Q4 24 | — | $-52.1M | ||
| Q3 24 | — | $-25.5M | ||
| Q2 24 | — | $-1.9M | ||
| Q1 24 | — | $-9.7M |
| Q4 25 | — | -565.1% | ||
| Q3 25 | 7.7% | -139.0% | ||
| Q2 25 | — | -111.0% | ||
| Q1 25 | — | -162.2% | ||
| Q4 24 | — | -54.8% | ||
| Q3 24 | — | -26.7% | ||
| Q2 24 | — | -1.4% | ||
| Q1 24 | — | -5.4% |
| Q4 25 | — | 914.0% | ||
| Q3 25 | 8.8% | 301.5% | ||
| Q2 25 | — | 154.2% | ||
| Q1 25 | — | 105.6% | ||
| Q4 24 | — | 100.0% | ||
| Q3 24 | — | 32.7% | ||
| Q2 24 | — | 2.2% | ||
| Q1 24 | — | 17.8% |
| Q4 25 | — | 1.30× | ||
| Q3 25 | 2.42× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.11× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
CORZ
| Other | $36.3M | 46% |
| Digital Asset Self Mining Service | $31.8M | 40% |
| Colocation Service | $11.6M | 15% |